Skip to main content
    E

    Exagen Inc (XGN)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $3.77
    -0.36 (-8.72%)

    Market Cap: $105.37M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Exagen Inc (XGN) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Exagen are Insight Molecular Diagnostics (IMDX), Precipio (PRPO) and Veracyte (VCYT). By market cap, Exagen ranks 9th of the 13 companies on this page; IDEXX Laboratories (IDXX) is the largest at $55.48B. The median P/E of the 5 companies with a P/E is 26.8x.

    Peer Comparison

    XGN's ROIC of -40.4% is below the peer median of 5.8%, and its revenue growth of 6.8% is above the median of 6.2%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Exagen (XGN)$105.37MN/A1.3x-25.1%-40.4%6.8%0.00%
    Insight Molecular Diagnostics Inc. (IMDX)$70.03MN/A40.9x0.0%197.8%-53.9%0.00%
    Precipio Inc (PRPO)$39.68MN/A1.3x-4.1%-5.7%8.3%0.00%
    Veracyte Inc (VCYT)$1.96B13.3x3.3x21.8%8.2%15.1%0.00%
    IDEXX Laboratories Inc (IDXX)$55.48B47.3x11.8x25.4%44.3%9.9%0.00%
    Atrium Therapeutics, Inc. Common Stock (RNA)$162.00MN/A3.3x-180.9%-44.5%24.2%0.00%
    Revvity Inc. (RVTY)$17.24B26.8x5.6x8.6%3.4%4.3%0.19%
    IQVIA Holdings Inc (IQV)$43.69B22.0x2.5x8.1%8.5%8.0%0.00%
    Myriad Genetics Inc (MYGN)$542.92MN/A0.7x-16.1%-29.5%-1.5%0.00%
    Adaptive Biotechnologies Corp (ADPT)$4.70BN/A15.0x-23.7%N/A-10.7%0.00%
    Anixa Biosciences Inc (ANIX)$91.08MN/AN/A0.0%N/A0.0%0.00%
    Agilent Technologies Inc (A)$49.05B28.5x6.6x19.5%13.1%8.1%0.59%
    MDxHealth SA (MDXH)$13.75MN/AN/A-38.3%-40.5%-17.2%0.00%
    Peer median$1.25B26.8x4.5x0.0%5.8%6.2%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Exagen, ranked by how closely their business, size, sector and industry match. The largest group, 10 of the 12, is in Diagnostics & Research; the other 2 are in Biotechnology.

    CompanyAboutPeers
    Insight Molecular Diagnostics Inc. (IMDX)Diagnostics & Research
    OncoCyte Corporation is a precision diagnostics company in the United States and internationally. The company is headquartered in Irvine, California.
    IMDX competitors
    Precipio Inc (PRPO)Diagnostics & Research
    Precipio, Inc., a cancer diagnostic and reagent technology company, provides diagnostic products and services in the United States oncology market.
    PRPO competitors
    Veracyte Inc (VCYT)Diagnostics & Research
    Veracyte, Inc. is a genomic diagnostics company in the United States and internationally. The company is headquartered in South San Francisco, California.
    VCYT competitors
    IDEXX Laboratories Inc (IDXX)Diagnostics & Research
    IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture...
    IDXX competitors
    Atrium Therapeutics, Inc. Common Stock (RNA)Biotechnology
    Avidity Biosciences, Inc., a biopharmaceutical company, is dedicated to the development of oligonucleotide-based therapies.
    RNA competitors
    Revvity Inc. (RVTY)Diagnostics & Research
    Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets globally.
    RVTY competitors
    IQVIA Holdings Inc (IQV)Diagnostics & Research
    IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology...
    IQV competitors
    Myriad Genetics Inc (MYGN)Diagnostics & Research
    Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized...
    MYGN competitors
    Adaptive Biotechnologies Corp (ADPT)Diagnostics & Research
    Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.
    ADPT competitors
    Anixa Biosciences Inc (ANIX)Biotechnology
    Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases.
    ANIX competitors
    Agilent Technologies Inc (A)Diagnostics & Research
    Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets...
    A competitors
    MDxHealth SA (MDXH)Diagnostics & Research
    MDxHealth SA is a prominent biotechnology company focused on precision diagnostics that enhance cancer management, particularly in prostate and bladder cancers.
    MDXH competitors

    Frequently Asked Questions About XGN

    Who are Exagen's main competitors?

    The companies most similar to Exagen include Insight Molecular Diagnostics (IMDX), Precipio (PRPO), Veracyte (VCYT), IDEXX Laboratories (IDXX) and Atrium Therapeutics, Inc. Common Stock (RNA), listed from the closest match.

    Who is Exagen's biggest competitor?

    IDEXX Laboratories (IDXX) is the largest of the similar companies at $55.48B; Insight Molecular Diagnostics (IMDX) is the closest match by business profile, size, sector and industry.

    How does XGN stock compare with its competitors?

    XGN's P/S is 1.3x against a peer median of 4.5x; its net margin is -25.1% against a peer median of 0.0%.

    Which of Exagen's competitors pays a higher dividend?

    Exagen pays no dividend. Agilent Technologies (A) and Revvity (RVTY) have higher forward dividend yields; Agilent Technologies (A) has the highest at 0.59%.

    Is Exagen bigger than its competitors?

    No. Exagen is 9th by market cap among the 13 companies on this page; the largest is IDEXX Laboratories (IDXX) at $55.48B.